Morecognition Company Profile

Background

Overview

Morecognition is an Italian startup founded in 2016, specializing in innovative solutions for the rehabilitation of motor-impaired patients, particularly those recovering from strokes. The company's mission is to enhance rehabilitation processes, enabling patients to regain autonomy and improve their quality of life. Their primary focus is on developing high-tech products and services in the fields of rehabilitation and ICT for health, well-being, and aging well.

Mission and Vision

Morecognition aims to revolutionize the rehabilitation landscape by integrating advanced technology with therapeutic practices, providing patients with tools that facilitate recovery in a home setting under professional supervision. Their vision is to make rehabilitation more accessible, effective, and personalized, thereby improving patient outcomes and promoting greater independence.

Industry Significance

Operating within the health and human services industry, Morecognition addresses a critical need for innovative rehabilitation solutions. By focusing on post-stroke recovery, the company contributes to a significant area of healthcare, offering alternatives to traditional rehabilitation methods and supporting the growing demand for telemedicine and digital health solutions.

Key Strategic Focus

Core Objectives

Morecognition's strategic focus centers on developing and deploying digital rehabilitation tools that empower patients to engage in their recovery process actively. By combining wearable technology with telemedicine, they aim to bridge the gap between clinical settings and home-based care, ensuring continuous monitoring and support.

Areas of Specialization

The company specializes in:

• Digital Rehabilitation Devices: Creating wearable devices that monitor and facilitate rehabilitation exercises.

• Telemedicine Integration: Enabling remote supervision and guidance from healthcare professionals.

• Patient Engagement Tools: Developing features that motivate and remind patients to adhere to their rehabilitation routines.

Key Technologies Utilized

Morecognition leverages several advanced technologies, including:

• Wearable Sensors: To track muscle activity and movement patterns.

• Artificial Intelligence (AI): For analyzing collected data and providing personalized feedback.

• Telecommunication Platforms: To facilitate real-time communication between patients and therapists.

Primary Markets Targeted

The company's solutions primarily target:

• Post-Stroke Patients: Individuals recovering from strokes who require ongoing rehabilitation.

• Healthcare Providers: Clinics and hospitals seeking to integrate digital rehabilitation tools into their services.

• Home Care Services: Organizations providing at-home care and rehabilitation support.

Financials and Funding

Funding History

Morecognition has secured funding through:

• Seed Round: On January 6, 2017, the company raised €50,000 in a seed funding round led by EASME, the EU Executive Agency for SMEs.

Total Funds Raised

The total funds raised by Morecognition amount to €50,000.

Notable Investors

The primary investor in the seed round was EASME.

Utilization of Capital

The capital raised has been utilized for:

• Product Development: Advancing the design and functionality of their rehabilitation devices.

• Research and Development: Conducting studies to validate the efficacy of their solutions.

• Market Expansion: Exploring opportunities in international markets, particularly in Europe.

Pipeline Development

Key Pipeline Candidates

Morecognition's flagship product is:

• Remo: A wearable device designed to assist post-stroke patients in regaining hand function through daily exercises supervised by physiotherapists.

Stages of Development

Remo has progressed through:

• Prototype Phase: Initial development and testing of the device.

• Clinical Trials: Studies demonstrating that Remo can help patients achieve up to 25% additional autonomy in the 12-18 months following discharge from the clinic.

Target Conditions

The primary condition targeted is:

• Post-Stroke Rehabilitation: Focusing on improving hand function and overall motor skills in stroke survivors.

Anticipated Milestones

Future milestones include:

• Product Launch: Introducing Remo to broader markets, including Germany, where the company has secured funding to analyze the physiotherapist market.

• Clinical Validation: Publishing comprehensive results from ongoing clinical studies to support product efficacy.

Technological Platform and Innovation

Proprietary Technologies

Morecognition's proprietary technologies encompass:

• Remo Device: A wearable medical device that measures and processes muscle activity data to facilitate rehabilitation exercises.

Significant Scientific Methods

The company employs:

• Electromyographic (EMG) Signal Processing: Utilizing muscle electrical signals to monitor and guide rehabilitation progress.

• Data Analytics: Applying AI algorithms to interpret collected data and provide personalized feedback.

AI-Driven Capabilities

Morecognition integrates AI to:

• Analyze Rehabilitation Data: Assess patient performance and adjust exercise plans accordingly.

• Enhance Patient Engagement: Offer tailored motivational prompts and reminders to encourage adherence to rehabilitation routines.

Leadership Team

Key Executives

• Paolo Ariano: